ciprofloxacin has been researched along with Drug Abuse, Intravenous in 11 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Antibiotic dosing was adjusted for renal dysfunction." | 2.68 | Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. ( Daoud, EG; Flexner, C; Goodman, SN; Hartert, TV; Heldman, AW; Kowalski, TE; Lietman, PS; Petty, BG; Pompili, VJ; Ray, SC; Sisson, SD; Tidmore, WC; vom Eigen, KA, 1996) |
| "While cutaneous anthrax is most common, its early stages are distinct and prompt appropriate treatment commonly produces a good outcome." | 2.48 | An overview of anthrax infection including the recently identified form of disease in injection drug users. ( Cui, X; Eichacker, PQ; Hicks, CW; Li, Y; Sweeney, DA, 2012) |
| "Two patients had acquired immunodeficiency syndrome (AIDS), one was human immunodeficiency virus (HIV)-positive, and the fourth refused HIV testing." | 1.29 | Spontaneous ulcerative keratitis in immunocompromised patients. ( Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM, 1993) |
| "A 35 year-old HIV-positive male intravenous drug abuser developed thrombotic thrombocytopenic purpura (TTP) during the course of recto-sigmoiditis secondary to Shigella flexneri." | 1.28 | Association of thrombotic thrombocytopenic purpura and human immunodeficiency virus infection. ( Beris, P; Dunand, V; Isoz, C; Reynard, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nair, MK | 1 |
| Patel, K | 1 |
| Starer, PJ | 1 |
| Hicks, CW | 1 |
| Sweeney, DA | 1 |
| Cui, X | 1 |
| Li, Y | 1 |
| Eichacker, PQ | 1 |
| Abdlslam, K | 1 |
| Thumbikat, P | 1 |
| Gibson, RJ | 1 |
| Baker, SD | 1 |
| Horger, DC | 1 |
| Keane, TE | 1 |
| Ender, M | 1 |
| Berger-Bächi, B | 1 |
| McCallum, N | 1 |
| Aristimuño, B | 1 |
| Nirankari, VS | 1 |
| Hemady, RK | 1 |
| Rodrigues, MM | 1 |
| Funke, G | 1 |
| Rosner, H | 1 |
| Heldman, AW | 1 |
| Hartert, TV | 1 |
| Ray, SC | 1 |
| Daoud, EG | 1 |
| Kowalski, TE | 1 |
| Pompili, VJ | 1 |
| Sisson, SD | 1 |
| Tidmore, WC | 1 |
| vom Eigen, KA | 1 |
| Goodman, SN | 1 |
| Lietman, PS | 1 |
| Petty, BG | 1 |
| Flexner, C | 1 |
| Lora-Tamayo, C | 1 |
| Tena, T | 1 |
| Rodriguez, A | 1 |
| Beris, P | 1 |
| Dunand, V | 1 |
| Isoz, C | 1 |
| Reynard, C | 1 |
| Dworkin, RJ | 1 |
| Lee, BL | 1 |
| Sande, MA | 1 |
| Chambers, HF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Partial Oral Antimicrobial Versus Intravenous Antimicrobial Therapy to Treat Infective Endocarditis in People Who Inject Drugs[NCT04544306] | 50 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ciprofloxacin and Drug Abuse, Intravenous
| Article | Year |
|---|---|
An overview of anthrax infection including the recently identified form of disease in injection drug users.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2012 |
Rahnella aquatilis bacteremia in an HIV-infected intravenous drug abuser.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Gram-Ne | 1995 |
1 trial available for ciprofloxacin and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercul | 1996 |
8 other studies available for ciprofloxacin and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Humans; Male; Methadone; Middle Aged; Narco | 2008 |
Anaerobic infection of the lumbar spine in an intravenous drug abuser.
Topics: Adult; Anaerobiosis; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Epidural Abscess; Female; Hu | 2002 |
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; | 2004 |
Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Deoxyribonucleases, Type II Site-Specific; | 2007 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candid | 1993 |
High concentration of ciprofloxacin in urine invalidates EMIT results.
Topics: Anti-Infective Agents; Ciprofloxacin; Enzyme Multiplied Immunoassay Technique; Forensic Medicine; Hu | 1996 |
Association of thrombotic thrombocytopenic purpura and human immunodeficiency virus infection.
Topics: Adult; Ciprofloxacin; HIV Infections; Humans; Male; Proctocolitis; Purpura, Thrombotic Thrombocytope | 1990 |
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.
Topics: Adult; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; End | 1989 |